OTC · ROIX
Response Oncology, Inc.
Healthcare · Medical - Care Facilities
$0.00
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 4:14 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 500
- Avg. volume
- 1.7K
Price performance
ROIX price history
1M range · 0 trading sessions · Daily adjusted prices
ROIX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ROIX news
The latest Smart Investors Daily articles mentioning ROIX.
Stock researchCompany · Overview
ROIX research
Overview
Company profile and research snapshot.
Company profile
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
